Biotechnology Entrepreneurship


From Science to Solutions



Michael L. Salgaller, PhD
First Edition, September 2010
216 Pages
Paperback ISBN: 978-1-934899-14-4 $64.95
Hardcover ISBN: 978-1-934899-13-7 $79.95

Distributed by Ingram and Baker & Taylor
Also available from Amazon.com

About the Editor

Michael L. Salgaller, PhD, has over 20 years of business and scientific and business experience in various life science sectors. He is an experienced industry and venture capital executive with a successful background in business development, strategic planning, technology assessment, and capital formation.
He has held various positions with consulting and drug discovery firms, as well as directing the development of cancer therapeutics.
Biotechnology Entrepreneurship
From Science to Solutions

Paperback: $64.95
  

Hardcover: $79.95
  

Also available from Amazon.com and other book retailers.

Bookstores and volume orders contact info@logos-press.com

Biotechnology Entrepreneurship: From Science to Solutions fills a critical gap in the biotechnology industry. For all the resources on how to start companies and on how to manage established companies in other sectors, there is a dearth of material on unique and critical issues in starting biotechnology companies, as well as managing the transition from start-up to established company. It is to this gap that Biotechnology Entrepreneurship is directed.
    Topics covered include:
    • Why Start a Biotechnology Company?
    • Company Formation and Organization
    • Building Your Team
    • Intellectual Property Protection Strategy
    • Financing Your Company
    • Partnering With Industry
    • Licensing and Technology Transfer
    • Regulatory Affairs
    • Roadmap to Reimbursement and Access
    • Working Toward a Successful Exit
    • Effective Networking
By combining the voices of a diverse set of industry insiders with extensive experience in biotechnology commercialization, Biotechnology Entrepreneurship prepares nascent founders, managers, investors, and other biotechnology company stakeholders to position themselves and their companies for commercial success.

See also...

The author's LinkedIn Profile